Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Lenskart Solutions Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹402
Per ShareLot Size
37 Shares
Minimum Investment
₹14,874
Issue Size
₹7,278.02 Cr
Face Value
₹2
Per ShareIPO Type
Book Building
Retail Quota
10%
QIB Quota
75%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
19.9%
Promoter Holding (Post-Issue)
17.71%
Issue Type
Book Building
ISIN
INE956O01016
We are a technology-driven eyewear company with integrated operations spanning designing, manufacturing, branding and retailing of eyewear products. We primarily sell prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories, under multiple brands and sub-brands. Our focus markets are India, Southeast Asia, Japan and the Middle East. We operate frame and lens design and eyeglass manufacturing facilities at two locations in India, supplemented by regional facilities in Singapore and the United Arab Emirates. We have an established presence across channels, including our websites, mobile applications and retail stores.
India is one of the fastest-growing retail markets, driven by urbanisation, rising disposable incomes, and a technology-proficient young population. The eyewear market in India is projected to expand at approximately 13% CAGR, reaching Rs.1,483 billion (approximately US$17.2 billion) by the Financial Year 2030. Prescription eyeglasses dominate with approximately 73% of market value. The rising global prevalence of refractive errors is driven by evolving lifestyles, coupled with an ageing population. Organised retail channels, driven by efficient supply chains and improved consumer experience, are projected to account for approximately 31% of India's eyewear market by the Financial Year 2030.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial public offering of up to 181,063,669 equity shares of face value of Rs.2/- each ("Equity Shares") of Lenskart Solutions Limited (the "Company" or the "Issuer") for cash at a price of Rs.402 per equity share of face value of Rs.2/- each (including a share Premium of Rs.400 per Equity Share) ("Offer Price"), aggregating up to Rs.7278.02 crores comprising a fresh issue of up to 53,501,096 equity shares of face value of Rs.2/- each, aggregating up to Rs.2150.00 crores by the company ("Fresh Issue") and an offer for sale of up to 127,562,573 equity shares of face value of Rs.2/- each, aggregating up to Rs.5128.00 crores ("Offered Shares") by Certain Shareholders ("(Selling Shareholders") (such sale, the "Offer for sale", and together with the fresh issue, the "Offer"). The offer includes a reservation of 391,644 equity shares of face value of Rs.2/- each, aggregating up to Rs. 15 crores (constituting up to 0.02% of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute 10.44% and 10.41% of the post-offer paid-up equity share capital of the company, respectively. The face value of equity shares is Rs.2 each. The offer price is 201 times the face value of the equity shares. The company, in consultation with the brlms, may consider a pre-ipo placement of specified securities aggregating up to Rs.430.00 crores, prior to filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. if the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the of the securities contracts (regulation) rules, 1957, as amended (the "scrr"). The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer. The company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result in listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if Undertaken). A discount of Rs. 19 per equity share is being offered to eligible employees bidding in the employee reservation portion.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Our Company was originally incorporated as `Valyoo Technologies Private Limited', as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated May 19, 2008, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana at New Delhi. Thereafter, the name of our Company was changed to `Lenskart Solutions Private Limited' pursuant to a fresh certificate of incorporation dated May 19, 2015, issued by the Registrar of Companies, Delhi and Haryana, at New Delhi (the "RoC"). Subsequently, our Company was converted to a public limited company and the name of our Company changed to `Lenskart Solutions Limited' pursuant to a resolution passed by our Board on May 21, 2025, and resolution passed by our Shareholders on May 30, 2025, and a fresh certificate of incorporation dated June 16, 2025, was issued by the RoC.
Wholesaler and Retailer
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
*Subject to approvals and market conditions.